Question 1
Question 2
Answer
-
increases drugs metabolism
-
decreases drug metabolism
-
decreases plasma concentrations of methylxanthines
-
doesn’ t change drugs metabolism
Question 3
Question
Nocebo effect is
Question 4
Question
When patient and doctor are aware of the contents of the formulation, the trial is defined as
Answer
-
open trial
-
blind trial
-
placebo trial
-
double-blind trial
Question 5
Question
Surrogates in rational pharmacotherapy are
Question 6
Question
Pharmacodynamic changes in elderly are
Answer
-
increased sensitivity to drugs suppressing central nervous system
-
decreased sensitivity to drugs suppressing central nervous system
-
paradoxal reactions are observed
-
adverse drug reactions are more frequent
Question 7
Question
Steady-state plasma concentration is
Answer
-
blood concentration of the drug 2 hours after administration
-
blood concentration of the drug after repeated administration when there is a balance between absorption and excretion
-
blood concentration of the drug after it has been ceased
-
blood concentration of the drug during its absorption
Question 8
Question
Drugs half-life is an index for
Answer
-
the route of administration of the drug
-
the duration of the drug effect when there is a relationship between it and plasma concentrations
-
time to reach steady-state plasma concentration after repeated administration
-
determination of dose interval
Question 9
Question
Drugs contraindicated in the first half of pregnancy are
Answer
-
Erythromycin
-
Sex steroids
-
Penicillins
-
Oral anticoagulants
Question 10
Question
For pharmacokinetics in elderly is true
Question 11
Question
Reasons for inadequate pharmaceutical availability are
Answer
-
chronic renal failure
-
improper use of the drug formulation
-
bad quality of the drug substance
-
participating in treatment
Question 12
Question
Categories of ADRs are
Answer
-
certain
-
probable
-
possible
-
unlikely
Question 13
Question
Therapeutic drug monitoring is
Answer
-
method for neuroleptanalgesy
-
used when there is relationship between plasma concentrations and drug effect
-
used for drugs with narrow therapeutic window
-
used for drugs with long half- live
Question 14
Question
Irrational ready-made drug formulations contain
Answer
-
drugs with different half-life
-
drugs for ethiotropic and symptomatic treatment
-
drugs with narrow therapeutic window
-
drugs affecting different pathogenic mechanisms
Question 15
Question
First phase of clinical trial can be determinated as
Answer
-
first application of a new substance to healthy volunteers
-
first application of a new substance to patients
-
efficacy and safety in a large number of patients
-
post-marketing surveillance in thousands of patients
Question 16
Question
Binding of drugs with plasma proteins is important for
Question 17
Question
Adverse drug reactions lead to
Answer
-
increased pharmacological effect
-
decreased risk of toxicity
-
decreased efficacy of the treatment
-
developement of unpredictable drug effects
Question 18
Question
Bad compliance of the patient may be due to
Answer
-
dose regimen with many drugs with frequent administration
-
a large number of drugs
-
lack of information for the treatment
-
the drug must be taken once daily
Question 19
Question
Fourth phase of clinical trial can be determinated as
Answer
-
first application of a new substance to healthy volunteers
-
first application of a new substance to patients
-
efficacy and safety in a large number of patients
-
post-marketing surveillance in thousands of patients
Question 20
Question
Drugs clearance is
Answer
-
Amount of drug, that reaches systemic circulation
-
Blood plasma volume from which the drug is eliminated for defined period of time
-
Steady- state plasma concentration
-
Withdrawal syndrome
Question 21
Question
Monitoring of therapeutic plasma concentrations is necessary for
Answer
-
theophyllin
-
phenobarbital
-
carbamazepin
-
amoxicillin
Question 22
Question
Third phase of clinical trial can be determinated as
Answer
-
first application of a new substance to healthy volunteers
-
first application of a new substance to patients
-
efficacy and safety in a large number of patients
-
post-marketing surveillance in thousands of patients
Question 23
Question
Clearance is an index for
Question 24
Question
Pharmacogenetic differences lead to
Question 25
Question
Drug surveillance is done by
Answer
-
spontaneous reporting
-
observation studies
-
family doctors
-
population statistics
Question 26
Question
Adverse drug reactions are the following types
Answer
-
augmented
-
bizarre
-
chronic
-
delayed
Question 27
Question
Mechanisms of drug interactions are
Answer
-
unpredictable
-
pharmacokinetic
-
pharmacodynamic
-
pharmaceutical
Question 28
Question
The quality of therapeutic decision (outcomes) can be measured by
Answer
-
clinical outcomes
-
costs — direct and indirect
-
functional status pf patient
-
overall patient satisfaction
Question 29
Question
Method of evaluation of cost/benefits ration are
Answer
-
cost minimization analysis
-
cost effectiveness analysis
-
cost utility analysis
-
cost consequence analysis
Question 30
Question
Drug metabolism involving some enzyme defects includes the following reactions
Answer
-
acetylation
-
oxidation
-
hydrolysis
-
red cells enzyme defects
Question 31
Question
The reasons for drug abuse are
Answer
-
relief of anxiety, tension and depression
-
entertainment, fun
-
improvement of performance in competitive sports
-
conformity with own social subgroup
Question 32
Question
How many types of dependence do you know?
Answer
-
psychological
-
physical (physiological)
-
acute
-
chronic
Question 33
Question
Which pharmacological drug groups cause drug dependence and tolerance?
Answer
-
Opioid analgesics
-
Antidepressants
-
CNS stimulants
-
Benzodiazepines
Question 34
Question
The neuropharmacological mechanisms of drug addiction are
Answer
-
activation of endogenous opiate encephalin receptors
-
activation of μ-opioid receptors in the brain
-
activation of cannabinoid receptors (CB1) in the hypothalamus
-
increase of glutamate release in the brain cortex
Question 35
Question
Benzodiazepine withdrawal syndrome is characterized by
Answer
-
it develops after 6-weeks of treatment
-
it develops after 2 weeks of treatment
-
psychological symptoms — anxiety, agitation, insomnia, seizures
-
physical symptoms — nausea, vomiting, muscle pain, ataxia
Question 36
Question
Opioid (heroin, morphine) withdrawal syndrome is characterized by
Answer
-
begins 8 hours after last dose
-
the peak is between 36-72 h
-
first physical symptoms are lacrimation, rhinorrhea and sweating
-
abdominal cramps, diarrhoea, bone and muscle pain, weakness and chills
Question 37
Question
Why is methadone used for treatment of opioid-dependence?